Jessica Chubak, PhD

Chubak_Jessica__205x293.jpg

“My research focuses on improving cancer control by finding effective ways to get screened for cancer and to navigate treatment and survivorship.”

Jessica Chubak, PhD

Senior Investigator, Kaiser Permanente Washington Health Research Institute

Biography

Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.

Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.

Research interests and experience

 

Recent publications

Chubak J, Hsu C, Tuzzio L, Kirlin B, Nekhlyudov L. C-a4-01: providing care for cancer survivors in integrated delivery systems: an assessment of current practices and future opportunities. Clin Med Res. 2010;8(3-4):182.

Chubak J, Boudreau DM, Fishman PA, Elmore JG. Cost of breast-related care in the year following false positive screening mammograms. Med Care. 2010;48(9):815-20. PubMed

Green BB, Wang CY, Horner K, Catz S, Meenan RT, Vernon SW, Carrell D, Chubak J, Ko C, Laing S, Bogart A. Systems of support to increase colorectal cancer screening and follow-up rates (SOS): Design, challenges, and baseline characteristics of trial participants. Contemp Clin Trials. 2010 Nov;31(6):589-603. Epub 2010 Jul 30. PubMed

Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to antidepressant medication use. Int J Cancer. 2011 Jan 1;128(1):227-32. Epub 2010 Mar 15. doi: 10.1002/ijc.25322. PubMed

Buist DS, Chubak J, Prout M, Yood MU, Bosco JL, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, Wei F, Silliman RA. Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence. J Clin Oncol. 2009;27(27):4508-14. Epub 2009 Aug 17. PubMed

Hudson SV, Chubak J, Coups EJ, Blake-Gumbs L, Jacobsen PB, Neugut AI, Buist DS. Identifying key questions to advance research and practice in cancer survivorship follow-up care: a report from the ASPO Survivorship Interest Group. Cancer Epidemiol Biomarkers Prev. 2009;18(7):2152-4. PubMed

Chubak J, Boudreau DM, Rulyak SJ, Mandelson MT. Colorectal cancer risk in relation to use of acid suppressive medications. Pharmacoepidemiol Drug Saf. 2009;18(7):540-4. Epub 2009 Apr 14. PubMed

 

healthy findings

Data-analysis_1col.jpg

Ask an epidemiologist: Where to learn about COVID-19

There’s much confusion about the new disease, but numbers don’t lie. The challenge is finding the right ones.

innovating care

Fit-Kit-Colon-testing_1col.jpg

How to maximize screening for colon cancer

Research informs care as Kaiser Permanente Washington, exceeding 80 percent screening rate, launches home-based 'FIT First' pilot.

Read about it in News and Events.

Cancer Research

PROSPR-blog_1col.jpg

Research funded to improve cancer screening

Drs. Kamineni and Chubak are among leaders of 2 new large PROSPR awards from NCI for cervical and colorectal cancer screening research.

Read it in News and Events.